Valneva SE
PAR:VLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valneva SE
PAR:VLA
|
FR |
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
B
|
Bangkok Life Assurance PCL
SET:BLA
|
TH |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
E
|
EQT Corp
XMUN:EQ6
|
US |
|
Snam SpA
F:SNM0
|
IT |
Wall St Price Targets
VLA Price Targets Summary
Valneva SE
According to Wall Street analysts, the average 1-year price target for VLA is 5.304 EUR with a low forecast of 2.121 EUR and a high forecast of 7.875 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VLA's stock price target?
Price Target
5.304
EUR
According to Wall Street analysts, the average 1-year price target for VLA is 5.304 EUR with a low forecast of 2.121 EUR and a high forecast of 7.875 EUR.
What is the Revenue forecast for Valneva SE?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 19%.
What is the Gross Profit forecast for Valneva SE?
Projected CAGR
48%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 48%.
